Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
about
Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesDevelopments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesAssociated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study.Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Pulse cyclophosphamide therapy for inflammatory bowel disease.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.Autoimmune neuromuscular disorders in childhoodThe heterogeneity of juvenile myositisJuvenile dermatomyositis: new insights and new treatment strategies.Current treatment strategies: collagen vascular diseases in childrenComparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.Consensus-based recommendations for the management of juvenile dermatomyositis.Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus.Review of dermatomyositis: establishing the diagnosis and treatment algorithm.Management of cutaneous dermatomyositis.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Treatment of Juvenile Dermatomyositis: An Update.Cyclophosphamide in dermatology.Pharmacological management of dermatomyositis.Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl.Chronic cutaneous varicella zoster virus infection complicating dermatomyositis.Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modelling.Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.The Vasculopathy of Juvenile Dermatomyositis
P2860
Q26798209-D1D8A1B2-B2BB-4DBC-8CF6-9F9867C7EC04Q26863125-C4217FB4-2B17-4339-BAB0-2E7D81047E3DQ33442153-CBBAD47C-2F1E-437A-88A0-71B83F799732Q33717793-F832E050-F724-45ED-AFC4-E24EF0A0E744Q33795594-19AA9352-3F6E-4568-BA1D-2DDE38501BF7Q34013209-82E3C6FA-6B7F-4B90-A4E9-E69777D4534DQ34349952-0C0E8831-A93B-43C0-9362-ADEC10F5B840Q35009335-7F6A2144-A3E6-4DF6-97D3-330B5768C3C7Q35267073-7BB97C7B-EFA5-46A4-ABF9-BDD14CB26C7AQ35512273-A0E80DB2-6CA9-464D-871C-9B9928F78C78Q35748264-3157FFD3-0E4F-41BA-A912-CE9A4BAA2292Q36059542-7A6C5D37-1F53-4B2F-A8B2-76EFD66887DCQ36458591-8F928AAC-90FA-47E5-9606-F32135D892C3Q36498667-82E0330E-2198-4859-BAC9-A5E6F8E626FDQ37617000-6DE295DE-CEA8-4BC3-935C-F7F6CAE59749Q37778652-45ACAC02-E09B-4CB5-A9E1-3FF4751F9936Q38017740-6097D7AC-D6A3-44E2-B205-989A3647339EQ38022271-AA5543BA-13FD-4448-B95C-620E9D5D6102Q38221095-2B38757A-71FD-4CE2-9074-183F6712C6B9Q38264788-5033896C-8399-493E-9301-FE66C6278F14Q38597575-FA316EDC-1412-407A-9F9B-66EF23C5BBD6Q38678257-2AF2F8F2-3370-4CA1-B6CD-AA221A805DFEQ38710150-BA17A88E-B723-413B-9A50-E6648DC0B173Q39425296-D2B1893A-0F27-4901-B749-2A67BA5735FFQ40168656-5753F46A-0E18-4668-870B-BAB3E6276CDEQ42240001-B03D6C64-3B92-4071-B06A-EF961C3D2FDFQ49998617-AFFF7A29-B7E9-4785-B28A-E7712BB1E67EQ51540185-13D10932-6FBD-499A-9D47-07E361A26B7AQ55284035-A6EAF610-1D17-459F-93F7-ECC3576816B5Q55512727-2CA5714F-D8D7-40D4-9644-1059A8F8883CQ57816912-6F6ED9F1-77C8-4270-B784-D3D7A0CD715B
P2860
Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@ast
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@en
type
label
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@ast
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@en
prefLabel
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@ast
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@en
P2093
P356
P1433
P1476
Intravenous cyclophosphamide p ...... review of efficacy and safety.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEH082
P577
2004-01-13T00:00:00Z